BenzingaOctober 7, 2026 at 4:18 AM NY20 Days Ago
Barclays Initiates Coverage On Boston Scientific with Equal-Weight Rating, Announces Price Target of $48
Barclays analyst Christopher Pasquale initiates coverage on Boston Scientific (NYSE:BSX) with a Equal-Weight rating and announces Price Target of $48.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
